盟科药业-U
(688373)
| 流通市值：33.07亿 | | | 总市值：33.07亿 |
| 流通股本：6.56亿 | | | 总股本：6.56亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 89,530,049.04 | 42,059,686.69 | 141,772,692.05 | 103,985,283.24 |
| 营业总成本 | 132,350,943.95 | 65,266,281.49 | 395,758,992.12 | 304,175,409.85 |
| 其他经营收益 | | | | |
| 营业利润 | -40,178,965.43 | -21,429,786.09 | -245,074,165.22 | -192,915,786.08 |
| 利润总额 | -40,163,675.43 | -21,429,836.09 | -245,565,529.83 | -193,407,150.71 |
| 净利润 | -37,566,012.58 | -21,453,649.71 | -241,612,359.49 | -193,536,147.26 |
| 每股收益 | | | | |
| 其他综合收益 | -5,452,230.97 | -2,424,500.46 | -9,392,194.42 | -5,117,441.93 |
| 综合收益总额 | -43,018,243.55 | -23,878,150.17 | -251,004,553.91 | -198,653,589.19 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 549,479,187.91 | 595,739,979.85 | 622,457,516.76 | 640,046,361.72 |
| 非流动资产: | | | | |
| 非流动资产合计 | 78,166,092.45 | 81,854,461.08 | 82,628,167.5 | 86,887,827.22 |
| 资产总计 | 627,645,280.36 | 677,594,440.93 | 705,085,684.26 | 726,934,188.94 |
| 流动负债: | | | | |
| 流动负债合计 | 252,628,358.6 | 288,020,068.66 | 224,379,941.7 | 276,413,708.51 |
| 非流动负债: | | | | |
| 非流动负债合计 | 212,070,470.85 | 207,636,786.73 | 275,166,474.93 | 192,966,402.11 |
| 负债合计 | 464,698,829.45 | 495,656,855.39 | 499,546,416.63 | 469,380,110.62 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 162,946,450.91 | 181,937,585.54 | 205,539,267.63 | 257,554,078.32 |
| 股东权益合计 | 162,946,450.91 | 181,937,585.54 | 205,539,267.63 | 257,554,078.32 |
| 负债和股东权益合计 | 627,645,280.36 | 677,594,440.93 | 705,085,684.26 | 726,934,188.94 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 109,721,730.78 | 62,311,107.23 | 162,639,221.74 | 117,706,977.25 |
| 经营活动现金流出小计 | 136,114,619.59 | 78,324,592.26 | 372,817,363.14 | 283,335,004.11 |
| 经营活动产生的现金流量净额 | -26,392,888.81 | -16,013,485.03 | -210,178,141.4 | -165,628,026.86 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,371,852,484.54 | 688,517,344.65 | 2,668,917,165.25 | 1,930,610,524.9 |
| 投资活动现金流出小计 | 1,348,437,335.23 | 666,115,758.01 | 2,503,425,950.47 | 1,753,725,494.86 |
| 投资活动产生的现金流量净额 | 23,415,149.31 | 22,401,586.64 | 165,491,214.78 | 176,885,030.04 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 20,050,000 | - | 208,816,683.69 | 91,702,238.69 |
| 筹资活动现金流出小计 | 49,362,119.15 | 13,858,265.51 | 140,506,136.82 | 37,650,658.55 |
| 筹资活动产生的现金流量净额 | -29,312,119.15 | -13,858,265.51 | 68,310,546.87 | 54,051,580.14 |
| 汇率变动对现金及现金等价物的影响 | -899,731.11 | -347,221.67 | -2,020,749.46 | -1,608,325.68 |
| 现金及现金等价物净增加额 | -33,189,589.76 | -7,817,385.57 | 21,602,870.79 | 63,700,257.64 |
| 期末现金及现金等价物余额 | 261,745,571.65 | 287,117,775.84 | 294,935,161.41 | 337,032,548.26 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -33,189,589.76 | - | 21,602,870.79 | - |